Showing results (51-60 of 81) with videos related to
Sort By:
Pageof 9
The Journal of Headache and Pain|January 8, 2021
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trialsStephen D Silberstein, Joshua M Cohen, Ronghua Yang, et al.Neurology|September 11, 2020
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized studyPeter J Goadsby, Stephen D Silberstein, Paul P Yeung, et al.Pain Management|June 9, 2021
PEARL study protocol: a real-world study of fremanezumab effectiveness in patients with chronic or episodic migraineMessoud Ashina, Faisal Mohammad Amin, Pinar Kokturk, et al.The Journal of Headache and Pain|December 19, 2021
Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS studyAntoinette MaassenVanDenBrink, Gisela M Terwindt, Joshua M Cohen, et al.Hand (New York, N.Y.)|December 20, 2024
Reevaluating the Need for Antibiotic Prophylaxis in Adult Upper Extremity Surgery With HardwareYufan Yan, Nathan Khabyeh-Hasbani, Rami Z Abuqubo, et al.JPRAS Open|November 11, 2025
Crouzonodermoskeletal syndrome requires individualized surgical management: Scoping review of a rare complex craniofacial syndromeHailey D Reisert, Matthew Goynatsky, Yair Cantor, et al.Journal of Clinical Anesthesia|August 25, 2016
Combined preoperative femoral and sciatic nerve blockade improves analgesia after anterior cruciate ligament reconstruction: a randomized controlled clinical trialMonica W Harbell, Joshua M Cohen, Kerstin Kolodzie, et al.European Journal of Neurology|March 18, 2022
Efficacy and quality-of-life improvements with fremanezumab treatment in patients with difficult-to-treat migraine with associated neurological dysfunctionChristian Lampl, Alan M Rapoport, Joshua M Cohen, et al.Headache|October 3, 2020
No "Wearing-Off Effect" Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long-Term StudyAndrew M Blumenfeld, Darko M Stevanovic, Mario Ortega, et al.JAMA Neurology|May 5, 2025
Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder: The UNITE Randomized Clinical TrialRichard B Lipton, Verena Ramirez Campos, Zipi Roth-Ben Arie, et al.Pageof 9